SBBI yields 8.16% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, SBBI + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SBBI + ABBV for your $10,000?
S.B.C.P. Bancorp, Inc. operates as the holding company for State Bank of Cross Plains that provides various personal and business financial services in Dane, Green, and Rock counties. It offers personal and business checking and savings accounts, individual retirement accounts, and certificates of deposit, as well as business, debit, and credit cards. The company also provides personal, home equity, student, construction and lot, and home loans, as well as refinance services; and small business loans and financing, commercial real estate and construction loans, letters of credit, small business administration loans, business credit lines, land development loans, commercial leasing services, merchant services, equipment leasing services, tax and capital lease services, and agriculture loans. In addition, it offers wealth and investment management, retirement and financial planning, and estate and trustee services, as well as online and mobile banking services; private banking services; and automated clearing house origination, wire transfer, positive pay, treasury and cash management, life and other insurance products, and payment services. The company serves customers through its full-service offices in Belleville, Black Earth, Brooklyn, Cross Plains, Evansville, Madison, Middleton, Mount Horeb, New Glarus, Oregon, Verona, and Waunakee, as well as a loan production office in Janesville and a motor bank in Cross Plains. S.B.C.P. Bancorp, Inc. was founded in 1908 and is based in Cross Plains, Wisconsin.
Full SBBI Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.